![News related image](/img/article-image-placeholder.webp)
![News related image](/img/article-image-placeholder.webp)
Successful Pig Kidney Transplant Offers Hope for Organ Failure Patients
66-year-old Tim Andrews, with end-stage kidney disease, received a successful pig kidney transplant at Massachusetts General Hospital on January 25, utilizing a genetically-modified organ from eGenesis via the FDA's Expanded Access pathway; this marks a major advancement in xenotransplantation, offe...
Successful Pig Kidney Transplant Offers Hope for Organ Failure Patients
66-year-old Tim Andrews, with end-stage kidney disease, received a successful pig kidney transplant at Massachusetts General Hospital on January 25, utilizing a genetically-modified organ from eGenesis via the FDA's Expanded Access pathway; this marks a major advancement in xenotransplantation, offe...
Progress
48% Bias Score
![News related image](/img/article-image-placeholder.webp)
![News related image](/img/article-image-placeholder.webp)
First Mice with Two Biological Fathers Created
Chinese scientists created the first mice with two biological fathers using embryonic stem cell engineering and CRISPR gene editing to correct imprinting abnormalities; although the mice had some health issues, the success demonstrates a potential pathway for gay male couples to have biologically re...
First Mice with Two Biological Fathers Created
Chinese scientists created the first mice with two biological fathers using embryonic stem cell engineering and CRISPR gene editing to correct imprinting abnormalities; although the mice had some health issues, the success demonstrates a potential pathway for gay male couples to have biologically re...
Progress
48% Bias Score
![News related image](/img/article-image-placeholder.webp)
![News related image](/img/article-image-placeholder.webp)
Groundbreaking Clinical Trials Anticipated in 2025
In 2025, several groundbreaking clinical trials will release preliminary data, including a large-scale US dietary study employing AI analysis (8,000+ adults), Oxford University's CBD trial for psychosis (1,000 patients), and research on personalized cancer vaccines.
Groundbreaking Clinical Trials Anticipated in 2025
In 2025, several groundbreaking clinical trials will release preliminary data, including a large-scale US dietary study employing AI analysis (8,000+ adults), Oxford University's CBD trial for psychosis (1,000 patients), and research on personalized cancer vaccines.
Progress
12% Bias Score
![News related image](/img/article-image-placeholder.webp)
![News related image](/img/article-image-placeholder.webp)
2024 Scientific Breakthroughs: Hope and Challenges for Humanity
2024 witnessed remarkable scientific progress in diverse fields, including AI, renewable energy, genetic engineering, and medicine, offering solutions to global issues like disease, hunger, and climate change, but also raising ethical concerns.
2024 Scientific Breakthroughs: Hope and Challenges for Humanity
2024 witnessed remarkable scientific progress in diverse fields, including AI, renewable energy, genetic engineering, and medicine, offering solutions to global issues like disease, hunger, and climate change, but also raising ethical concerns.
Progress
48% Bias Score
![News related image](/img/article-image-placeholder.webp)
NHS to Offer £1.65m Gene Therapy for Sickle Cell Disease
England's NHS will offer the £1.65m gene-editing therapy Casgevy to about 50 sickle cell patients yearly, marking a major advance in treating this life-threatening blood disorder primarily affecting people of Black African and Black Caribbean heritage, offering a potential cure and improved quality ...
![News related image](/img/article-image-placeholder.webp)
NHS to Offer £1.65m Gene Therapy for Sickle Cell Disease
England's NHS will offer the £1.65m gene-editing therapy Casgevy to about 50 sickle cell patients yearly, marking a major advance in treating this life-threatening blood disorder primarily affecting people of Black African and Black Caribbean heritage, offering a potential cure and improved quality ...
Progress
44% Bias Score
![News related image](/img/article-image-placeholder.webp)
mvGPT: A Revolutionary Gene Editing Technology
Rice University researchers developed mvGPT, a compact gene editing technology enabling simultaneous gene editing, activation, and repression; successful in treating Wilson's disease, Type I diabetes, and Transthyretin amyloidosis.
![News related image](/img/article-image-placeholder.webp)
mvGPT: A Revolutionary Gene Editing Technology
Rice University researchers developed mvGPT, a compact gene editing technology enabling simultaneous gene editing, activation, and repression; successful in treating Wilson's disease, Type I diabetes, and Transthyretin amyloidosis.
Progress
48% Bias Score
![News related image](/img/article-image-placeholder.webp)
2025: AI's Dual Impact and Technological Advancements
In 2025, AI will significantly impact daily life, revolutionizing sectors like medicine and transportation, while also raising concerns about job displacement and the spread of misinformation; renewable energy and battery technology advancements aim to combat climate change, while CRISPR technology ...
![News related image](/img/article-image-placeholder.webp)
2025: AI's Dual Impact and Technological Advancements
In 2025, AI will significantly impact daily life, revolutionizing sectors like medicine and transportation, while also raising concerns about job displacement and the spread of misinformation; renewable energy and battery technology advancements aim to combat climate change, while CRISPR technology ...
Progress
40% Bias Score